Literature DB >> 20595011

Aging, antagonistic pleiotropy and fibrotic disease.

Victor J Thannickal1.   

Abstract

Tissue fibrosis is most often referred to in its pathological context and is a major cause of progressive organ failure and death. Here, we consider fibrosis as an evolutionarily conserved, adaptive tissue response to injury. The role of NADPH oxidase 4 (Nox4) as a novel pro-fibrogenic mediator is highlighted. The concept that Nox4 may function as an antagonistically pleiotropic gene in age-associated fibrotic disorders is discussed. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595011      PMCID: PMC2910205          DOI: 10.1016/j.biocel.2010.05.010

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  16 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Idiopathic pulmonary fibrosis: a disorder of lung regeneration?

Authors:  Victor J Thannickal; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2008-10-01       Impact factor: 21.405

Review 3.  Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.

Authors:  Hideki Sumimoto
Journal:  FEBS J       Date:  2008-05-30       Impact factor: 5.542

4.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

5.  Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.

Authors:  Tianju Liu; Myoung Ja Chung; Matthew Ullenbruch; Hongfeng Yu; Hong Jin; Biao Hu; Yoon Young Choi; Fuyuki Ishikawa; Sem H Phan
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia.

Authors:  Andrei Tchirkov; Peter M Lansdorp
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

7.  Telomere shortening in familial and sporadic pulmonary fibrosis.

Authors:  Jennifer T Cronkhite; Chao Xing; Ganesh Raghu; Kelly M Chin; Fernando Torres; Randall L Rosenblatt; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

8.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis.

Authors:  Jonathan K Alder; Julian J-L Chen; Lisa Lancaster; Sonye Danoff; Shu-chih Su; Joy D Cogan; Irma Vulto; Mingyi Xie; Xiaodong Qi; Rubin M Tuder; John A Phillips; Peter M Lansdorp; James E Loyd; Mary Y Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

9.  Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes.

Authors:  Tsukasa Kawahara; Mark T Quinn; J David Lambeth
Journal:  BMC Evol Biol       Date:  2007-07-06       Impact factor: 3.260

10.  NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.

Authors:  Louise Hecker; Ragini Vittal; Tamara Jones; Rajesh Jagirdar; Tracy R Luckhardt; Jeffrey C Horowitz; Subramaniam Pennathur; Fernando J Martinez; Victor J Thannickal
Journal:  Nat Med       Date:  2009-08-23       Impact factor: 53.440

View more
  22 in total

Review 1.  Fibrosis: ultimate and proximate causes.

Authors:  Victor J Thannickal; Yong Zhou; Amit Gaggar; Steven R Duncan
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry.

Authors:  Anuradha Vivekanandan-Giri; Jaeman Byun; Subramaniam Pennathur
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

Review 3.  Diverse origins of the myofibroblast—implications for kidney fibrosis.

Authors:  Lucas L Falke; Shima Gholizadeh; Roel Goldschmeding; Robbert J Kok; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2015-01-13       Impact factor: 28.314

Review 4.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

5.  Getting to the core of fibrosis: targeting redox imbalance in aging.

Authors:  Louise Hecker; Victor J Thannickal
Journal:  Ann Transl Med       Date:  2016-03

Review 6.  Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

Authors:  Sunad Rangarajan; Morgan L Locy; Tracy R Luckhardt; Victor J Thannickal
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

7.  Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Respir Med       Date:  2012-01-31       Impact factor: 3.415

Review 8.  Biomarkers for the identification of cardiac fibroblast and myofibroblast cells.

Authors:  Emiri Tarbit; Indu Singh; Jason N Peart; Roselyn B Rose'Meyer
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

9.  Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.

Authors:  Yen-Ting Chen; Pei-Yu Jhao; Chen-Ting Hung; Yueh-Feng Wu; Sung-Jan Lin; Wen-Chih Chiang; Shuei-Liong Lin; Kai-Chien Yang
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

10.  Sarcoidosis-related mortality in the United States from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2011-02-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.